Inverted head and shoulders. Buyers absorbing pot

Inverted head and shoulders. Buyers absorbing potential dilution quickly. Too much riding on the trial launch and WORLD WIDE exposure. Not saying it'll happen, but I like the potential to be back in the .20's and with trial launch, with impressive protocols, we could see quite a run up. Whoever took the deal is looking for IPIX's success, not just trying to make a buck and dilute the crap out of us. Otherwise we'd have been punching .10 or lower already.

But that, my friends, is ONLY my opinion.